|
|
|
|
Agape Atp Corporation (NASDAQ: ATPC) |
|
Price: $1.0300
$0.01 
0.980%
|
| Day's High:
| $1.04
| Week Perf:
| 1.98 %
|
| Day's Low: |
$ 1.02 |
30 Day Perf: |
8.42 % |
| Volume (M): |
14 |
52 Wk High: |
$ 3.49 |
| Volume (M$): |
$ 15 |
52 Wk Avg: |
$1.02 |
| Open: |
$1.04 |
52 Wk Low: |
$0.07 |
|
|
| Market Capitalization (Millions $) |
4 |
| Shares
Outstanding (Millions) |
4 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Agape Atp Corporation
Company Address: 1705 - 1708, Level 17, Tower 2, Faber Tower Kuala Lumpur 58100
Company Phone Number: 192230099 Stock Exchange / Ticker: NASDAQ ATPC
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Anika Therapeutics Inc
For the financial period closing December 31 2024 ANIK decreased a loss per share of $-1.50 per share compare to $-4.29 a year ago and EPS improved from $-2.03 per share from the previous financial reporting period. The Revenue advanced by 7.334 % to $46.42 million from $43.25 million in the comparable financial reporting period a year ago and sequentially revenue improved by 20.76 % from $38.44 million. ANIKs' has clearly exceeded its industry peers on the revenue side, as the rest of the Medical Equipment and Supplies industry show 0.45% during the same period top-line rise thus far.
|
|
Nexalin Technology Inc
Focusing on the fourth quarter of 2024 the Medical Equipment and Supplies company reached balanced books at $0.00 per share, relative to the results of $-0.38 per share a year prior financial reporting period, In the previous financial reporting period the Nexalin Technology Inc realized $-0.23 per share.
|
|
Odyssey Health Inc
The Medical Equipment and Supplies sector advisors start to scrutinize the second quarter of 2025 results. Now they observe operating loss of $-0.156593 million, from the Odyssey Health Inc , which has not stated any top-line so far, for the respective November to January 31 2025 reporting season.
|
|
Lyra Therapeutics Inc
For the October to December 31 2024 time-frame company decreased a loss per share of $-0.15 per share compare to $-0.19 a year ago and EPS improved from $-0.18 per share from the preceding reporting period. The revenue jumped by 43.151 % to $0.21 million from $0.15 million in the same reporting period a year ago and sequentially revenue advanced by 7.179 % from $0.20 million. Lyra Therapeutics Inc s' flourishes in the fourth quarter of 2024, while most of the corporations in the Medical Equipment and Supplies industries are experiencing challenges with the Receding businesses and experiencing diminishing revenue.
|
|
Heartbeam Inc
For the fourth quarter of 2024 earnings season BEAT slipped into deficit of $-0.18 per share compare to $0.04 a year before and earnings per share fell from $0.18 per share from the previous quarter. The revenue remained unchanged to $0.00 million from $112.03 million in the corresponding quarter a year before and sequentially from $114.66 million.
|
| Per Share |
Current |
| Earnings (TTM) |
-0.15 $ |
| Revenues (TTM) |
0.25 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.7 $
|
| Book Value |
0.71 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.15 $
|
| Revenues (TTM) |
0.25 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.7 $
|
| Book Value |
0.71 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Energized Mineral Concentrate |
|
 0.33 % |
of total Revenue |
| LIVO 5 |
|
7.28 % |
of total Revenue |
| Soy Protein Isolate Powder |
|
0.69 % |
of total Revenue |
| Mix Soy Protein Isolate Powder with Black Sesame |
|
0.5 % |
of total Revenue |
| Product Health Therapies |
|
68.6 % |
of total Revenue |
| Skin Care And Health Care Products |
|
5.56 % |
of total Revenue |
| Product |
|
82.94 % |
of total Revenue |
| Health and Wellness Services |
|
17.06 % |
of total Revenue |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
1.19%